Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Subarachnoid Hemorrhage | 7 | 2025 | 59 | 2.790 |
Why?
|
Vasospasm, Intracranial | 3 | 2025 | 18 | 1.880 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 215 | 1.320 |
Why?
|
Brain Ischemia | 2 | 2022 | 85 | 1.140 |
Why?
|
Surveys and Questionnaires | 4 | 2020 | 971 | 1.070 |
Why?
|
Neurosurgical Procedures | 6 | 2024 | 220 | 1.050 |
Why?
|
Subarachnoid Hemorrhage, Traumatic | 1 | 2024 | 2 | 0.900 |
Why?
|
Neurosurgeons | 2 | 2021 | 22 | 0.880 |
Why?
|
Neurosurgery | 2 | 2021 | 75 | 0.790 |
Why?
|
Stroke | 3 | 2022 | 252 | 0.790 |
Why?
|
Pandemics | 2 | 2020 | 186 | 0.760 |
Why?
|
Human Activities | 1 | 2021 | 6 | 0.750 |
Why?
|
Time | 1 | 2021 | 16 | 0.750 |
Why?
|
Terminology as Topic | 1 | 2021 | 56 | 0.720 |
Why?
|
Education, Medical, Continuing | 1 | 2020 | 34 | 0.670 |
Why?
|
Intracranial Aneurysm | 5 | 2023 | 58 | 0.670 |
Why?
|
Betacoronavirus | 1 | 2020 | 39 | 0.660 |
Why?
|
Embolization, Therapeutic | 4 | 2017 | 47 | 0.650 |
Why?
|
Humans | 39 | 2025 | 28094 | 0.650 |
Why?
|
Brain Mapping | 3 | 2017 | 201 | 0.650 |
Why?
|
Coronavirus Infections | 1 | 2020 | 49 | 0.640 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 53 | 0.640 |
Why?
|
Hypertension | 1 | 2022 | 308 | 0.630 |
Why?
|
Mechanical Thrombolysis | 1 | 2017 | 3 | 0.550 |
Why?
|
Cerebral Hemorrhage | 1 | 2017 | 91 | 0.510 |
Why?
|
Dimethyl Sulfoxide | 1 | 2015 | 11 | 0.480 |
Why?
|
Polyvinyls | 1 | 2015 | 14 | 0.480 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2015 | 16 | 0.470 |
Why?
|
Carotid Stenosis | 1 | 2015 | 27 | 0.470 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 145 | 0.440 |
Why?
|
Middle Aged | 15 | 2024 | 7137 | 0.420 |
Why?
|
Magnetic Resonance Imaging | 8 | 2024 | 819 | 0.380 |
Why?
|
Personal Protective Equipment | 2 | 2021 | 14 | 0.360 |
Why?
|
Archaeology | 2 | 2021 | 59 | 0.360 |
Why?
|
Aged | 11 | 2024 | 5400 | 0.350 |
Why?
|
Female | 17 | 2024 | 15153 | 0.350 |
Why?
|
Retrospective Studies | 7 | 2024 | 2546 | 0.340 |
Why?
|
Aneurysm, False | 2 | 2022 | 19 | 0.340 |
Why?
|
Treatment Outcome | 7 | 2025 | 2377 | 0.330 |
Why?
|
Tomography, X-Ray Computed | 3 | 2024 | 474 | 0.310 |
Why?
|
Subclavian Steal Syndrome | 1 | 2008 | 3 | 0.310 |
Why?
|
Stents | 3 | 2023 | 120 | 0.300 |
Why?
|
Postoperative Complications | 3 | 2023 | 611 | 0.300 |
Why?
|
Male | 16 | 2024 | 13489 | 0.280 |
Why?
|
Mitral Valve | 2 | 2024 | 63 | 0.270 |
Why?
|
Adult | 9 | 2024 | 7739 | 0.270 |
Why?
|
Cerebrovascular Circulation | 1 | 2008 | 220 | 0.260 |
Why?
|
Obesity | 2 | 2023 | 669 | 0.260 |
Why?
|
Cerebral Angiography | 4 | 2017 | 38 | 0.260 |
Why?
|
Achondroplasia | 1 | 2005 | 2 | 0.250 |
Why?
|
Arachnoid Cysts | 1 | 2005 | 4 | 0.250 |
Why?
|
Thrombectomy | 2 | 2016 | 28 | 0.250 |
Why?
|
Palatine Tonsil | 1 | 2005 | 10 | 0.250 |
Why?
|
Hernia | 1 | 2005 | 9 | 0.250 |
Why?
|
Syringomyelia | 1 | 2005 | 9 | 0.250 |
Why?
|
Nimodipine | 1 | 2025 | 7 | 0.240 |
Why?
|
Calcium Channel Blockers | 1 | 2025 | 40 | 0.240 |
Why?
|
Endovascular Procedures | 2 | 2023 | 70 | 0.230 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2024 | 6 | 0.230 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2024 | 3 | 0.230 |
Why?
|
Ventricular Septum | 1 | 2024 | 3 | 0.230 |
Why?
|
Patient Care Team | 1 | 2025 | 67 | 0.230 |
Why?
|
Thyroid Neoplasms | 1 | 2025 | 39 | 0.230 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2024 | 12 | 0.230 |
Why?
|
Cardiac Surgical Procedures | 2 | 2024 | 173 | 0.230 |
Why?
|
Multimodal Imaging | 1 | 2024 | 22 | 0.230 |
Why?
|
Laryngoscopes | 1 | 2024 | 1 | 0.230 |
Why?
|
Laryngoscopy | 1 | 2024 | 5 | 0.230 |
Why?
|
Hemangioendothelioma, Epithelioid | 1 | 2024 | 5 | 0.220 |
Why?
|
Echocardiography, Transesophageal | 1 | 2024 | 43 | 0.220 |
Why?
|
Tissue Plasminogen Activator | 2 | 2022 | 36 | 0.220 |
Why?
|
Intubation, Intratracheal | 1 | 2024 | 27 | 0.220 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2024 | 40 | 0.220 |
Why?
|
Brain Injuries, Traumatic | 1 | 2024 | 36 | 0.220 |
Why?
|
Pediatrics | 1 | 2025 | 92 | 0.220 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 126 | 0.210 |
Why?
|
Sinus of Valsalva | 1 | 2022 | 13 | 0.200 |
Why?
|
Robotic Surgical Procedures | 1 | 2023 | 45 | 0.200 |
Why?
|
Incidence | 1 | 2024 | 562 | 0.200 |
Why?
|
Postoperative Period | 1 | 2022 | 67 | 0.190 |
Why?
|
Drainage | 1 | 2022 | 45 | 0.190 |
Why?
|
Aortic Valve | 1 | 2022 | 92 | 0.190 |
Why?
|
Angiography, Digital Subtraction | 3 | 2017 | 19 | 0.190 |
Why?
|
Geology | 1 | 2021 | 2 | 0.190 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 112 | 0.190 |
Why?
|
History, 21st Century | 1 | 2021 | 49 | 0.180 |
Why?
|
Natural Resources | 1 | 2021 | 1 | 0.180 |
Why?
|
Genetic Predisposition to Disease | 1 | 2024 | 666 | 0.180 |
Why?
|
Microsurgery | 3 | 2011 | 45 | 0.180 |
Why?
|
History, 20th Century | 1 | 2021 | 84 | 0.180 |
Why?
|
Spinal Cord | 2 | 2015 | 209 | 0.170 |
Why?
|
Patient Selection | 2 | 2015 | 148 | 0.170 |
Why?
|
Canada | 1 | 2020 | 60 | 0.170 |
Why?
|
Child | 4 | 2025 | 2242 | 0.170 |
Why?
|
Nerve Regeneration | 1 | 2020 | 12 | 0.170 |
Why?
|
Workload | 1 | 2020 | 38 | 0.170 |
Why?
|
Delivery of Health Care | 1 | 2021 | 118 | 0.170 |
Why?
|
Folic Acid | 1 | 2020 | 32 | 0.160 |
Why?
|
Health Personnel | 1 | 2020 | 95 | 0.160 |
Why?
|
Prospective Studies | 3 | 2024 | 1248 | 0.160 |
Why?
|
Neurocysticercosis | 1 | 2018 | 13 | 0.150 |
Why?
|
Curriculum | 1 | 2020 | 291 | 0.150 |
Why?
|
Arnold-Chiari Malformation | 1 | 2018 | 13 | 0.150 |
Why?
|
Neurons | 1 | 2020 | 283 | 0.140 |
Why?
|
Hydrocephalus | 1 | 2018 | 52 | 0.140 |
Why?
|
Vertebral Artery Dissection | 1 | 2017 | 4 | 0.140 |
Why?
|
Aged, 80 and over | 4 | 2017 | 2021 | 0.140 |
Why?
|
Glasgow Outcome Scale | 1 | 2017 | 3 | 0.140 |
Why?
|
Plasminogen Activators | 1 | 2017 | 7 | 0.140 |
Why?
|
Internship and Residency | 1 | 2020 | 239 | 0.140 |
Why?
|
Risk Factors | 1 | 2022 | 2081 | 0.130 |
Why?
|
Brain | 2 | 2013 | 741 | 0.130 |
Why?
|
Mobile Health Units | 1 | 2016 | 2 | 0.130 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2016 | 16 | 0.130 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 22 | 0.130 |
Why?
|
Computed Tomography Angiography | 1 | 2016 | 24 | 0.130 |
Why?
|
Point-of-Care Systems | 1 | 2016 | 21 | 0.130 |
Why?
|
Thrombolytic Therapy | 1 | 2016 | 39 | 0.130 |
Why?
|
Triage | 1 | 2016 | 33 | 0.130 |
Why?
|
Arteriovenous Malformations | 1 | 2015 | 16 | 0.120 |
Why?
|
Cerebral Revascularization | 1 | 2015 | 11 | 0.120 |
Why?
|
Fluoroscopy | 1 | 2015 | 34 | 0.120 |
Why?
|
Cerebral Infarction | 1 | 2015 | 26 | 0.120 |
Why?
|
Middle Cerebral Artery | 2 | 2015 | 48 | 0.120 |
Why?
|
Executive Function | 1 | 2015 | 25 | 0.120 |
Why?
|
Disease Progression | 2 | 2015 | 473 | 0.120 |
Why?
|
Aging | 2 | 2013 | 968 | 0.110 |
Why?
|
United States | 1 | 2020 | 2146 | 0.110 |
Why?
|
Chronic Disease | 1 | 2015 | 271 | 0.110 |
Why?
|
Magnetic Resonance Angiography | 2 | 2016 | 28 | 0.110 |
Why?
|
Motor Activity | 2 | 2013 | 148 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2015 | 385 | 0.100 |
Why?
|
Meningeal Neoplasms | 2 | 2011 | 73 | 0.100 |
Why?
|
Meningioma | 2 | 2011 | 79 | 0.100 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 371 | 0.100 |
Why?
|
Language | 1 | 2013 | 63 | 0.100 |
Why?
|
Evoked Potentials, Motor | 1 | 2011 | 21 | 0.090 |
Why?
|
Skull Base Neoplasms | 1 | 2011 | 21 | 0.090 |
Why?
|
Thoracic Vertebrae | 2 | 2024 | 67 | 0.080 |
Why?
|
Aneurysm | 2 | 2009 | 25 | 0.080 |
Why?
|
DNA Methylation | 2 | 2020 | 152 | 0.080 |
Why?
|
Basilar Artery | 1 | 2008 | 7 | 0.080 |
Why?
|
Subclavian Artery | 1 | 2008 | 14 | 0.080 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 129 | 0.070 |
Why?
|
Neuronavigation | 1 | 2006 | 9 | 0.060 |
Why?
|
Ultrasonics | 1 | 2006 | 7 | 0.060 |
Why?
|
Monitoring, Intraoperative | 1 | 2006 | 30 | 0.060 |
Why?
|
Surgery, Computer-Assisted | 1 | 2006 | 33 | 0.060 |
Why?
|
Vascular Surgical Procedures | 1 | 2006 | 54 | 0.060 |
Why?
|
Radiography | 1 | 2005 | 202 | 0.060 |
Why?
|
Delphi Technique | 1 | 2025 | 21 | 0.060 |
Why?
|
Thyroid Gland | 1 | 2025 | 32 | 0.060 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2024 | 2 | 0.060 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2024 | 10 | 0.060 |
Why?
|
Consensus | 1 | 2025 | 75 | 0.060 |
Why?
|
Glioma | 1 | 2006 | 117 | 0.060 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2024 | 8 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2017 | 1013 | 0.060 |
Why?
|
Tooth Injuries | 1 | 2024 | 2 | 0.060 |
Why?
|
Operating Rooms | 1 | 2024 | 19 | 0.060 |
Why?
|
Genetic Testing | 1 | 2024 | 68 | 0.060 |
Why?
|
Video Recording | 1 | 2024 | 39 | 0.050 |
Why?
|
Spinal Cord Neoplasms | 1 | 2024 | 35 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2024 | 75 | 0.050 |
Why?
|
Spinal Neoplasms | 1 | 2024 | 39 | 0.050 |
Why?
|
Surgical Procedures, Operative | 1 | 2024 | 50 | 0.050 |
Why?
|
Cross-Over Studies | 1 | 2024 | 134 | 0.050 |
Why?
|
Absorbable Implants | 1 | 2023 | 16 | 0.050 |
Why?
|
Decompression, Surgical | 1 | 2024 | 76 | 0.050 |
Why?
|
Analgesics | 1 | 2023 | 38 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 243 | 0.050 |
Why?
|
Brain Neoplasms | 1 | 2006 | 301 | 0.050 |
Why?
|
Genistein | 1 | 2002 | 9 | 0.050 |
Why?
|
Echocardiography, Doppler | 1 | 2022 | 21 | 0.050 |
Why?
|
Pain, Postoperative | 1 | 2023 | 62 | 0.050 |
Why?
|
Transcranial Magnetic Stimulation | 2 | 2013 | 14 | 0.050 |
Why?
|
Risk Assessment | 1 | 2024 | 612 | 0.050 |
Why?
|
Aorta | 1 | 2022 | 124 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2023 | 113 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2022 | 137 | 0.050 |
Why?
|
Feasibility Studies | 1 | 2022 | 193 | 0.050 |
Why?
|
Arabia | 1 | 2021 | 1 | 0.050 |
Why?
|
Mesopotamia | 1 | 2021 | 1 | 0.050 |
Why?
|
Climate | 1 | 2021 | 33 | 0.050 |
Why?
|
History, Ancient | 1 | 2021 | 35 | 0.050 |
Why?
|
Conservation of Natural Resources | 1 | 2021 | 31 | 0.040 |
Why?
|
Oxygen | 2 | 2013 | 233 | 0.040 |
Why?
|
Elective Surgical Procedures | 1 | 2021 | 70 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2016 | 414 | 0.040 |
Why?
|
Pain | 1 | 2023 | 258 | 0.040 |
Why?
|
Biodiversity | 1 | 2021 | 112 | 0.040 |
Why?
|
Cadaver | 2 | 2011 | 57 | 0.040 |
Why?
|
Azacitidine | 1 | 2020 | 8 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2013 | 251 | 0.040 |
Why?
|
Injections, Intraperitoneal | 1 | 2020 | 35 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2024 | 356 | 0.040 |
Why?
|
Hydroxamic Acids | 1 | 2020 | 18 | 0.040 |
Why?
|
Axons | 1 | 2020 | 24 | 0.040 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2020 | 26 | 0.040 |
Why?
|
Genome | 1 | 2020 | 56 | 0.040 |
Why?
|
Administration, Oral | 1 | 2020 | 189 | 0.040 |
Why?
|
Ecosystem | 1 | 2021 | 225 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 1 | 2020 | 551 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2020 | 403 | 0.040 |
Why?
|
Phenotype | 1 | 2020 | 680 | 0.030 |
Why?
|
Reperfusion | 1 | 2016 | 7 | 0.030 |
Why?
|
Remote Consultation | 1 | 2016 | 4 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2016 | 37 | 0.030 |
Why?
|
Blood Vessel Prosthesis | 1 | 2016 | 28 | 0.030 |
Why?
|
Young Adult | 2 | 2015 | 2732 | 0.030 |
Why?
|
Prosthesis Design | 1 | 2016 | 87 | 0.030 |
Why?
|
Patient Transfer | 1 | 2016 | 43 | 0.030 |
Why?
|
Recovery of Function | 1 | 2016 | 118 | 0.030 |
Why?
|
Semantics | 1 | 2013 | 11 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2015 | 885 | 0.020 |
Why?
|
Infant | 1 | 2015 | 1004 | 0.020 |
Why?
|
Child, Preschool | 1 | 2015 | 1146 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2013 | 391 | 0.020 |
Why?
|
Sphenoid Sinus | 1 | 2011 | 5 | 0.020 |
Why?
|
Orbit | 1 | 2011 | 8 | 0.020 |
Why?
|
Facial Bones | 1 | 2011 | 7 | 0.020 |
Why?
|
Bacteria, Aerobic | 1 | 2011 | 4 | 0.020 |
Why?
|
Skull Base | 1 | 2011 | 34 | 0.020 |
Why?
|
Aneurysm, Ruptured | 1 | 2011 | 17 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 95 | 0.020 |
Why?
|
Reaction Time | 1 | 2011 | 94 | 0.020 |
Why?
|
Seasons | 1 | 2011 | 89 | 0.020 |
Why?
|
Neuroimaging | 1 | 2011 | 87 | 0.020 |
Why?
|
Movement | 1 | 2011 | 97 | 0.020 |
Why?
|
Electromyography | 1 | 2011 | 175 | 0.020 |
Why?
|
Muscle Contraction | 1 | 2011 | 170 | 0.020 |
Why?
|
Animals | 2 | 2020 | 10415 | 0.020 |
Why?
|
Dissection | 1 | 2009 | 20 | 0.020 |
Why?
|
Vertebral Artery | 1 | 2009 | 16 | 0.020 |
Why?
|
Cerebellum | 1 | 2009 | 41 | 0.020 |
Why?
|
Consciousness Disorders | 1 | 2006 | 1 | 0.020 |
Why?
|
Selection Bias | 1 | 2006 | 13 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2006 | 21 | 0.020 |
Why?
|
Seizures | 1 | 2006 | 48 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2006 | 106 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2006 | 163 | 0.010 |
Why?
|
Survival Rate | 1 | 2006 | 430 | 0.010 |
Why?
|
Length of Stay | 1 | 2006 | 229 | 0.010 |
Why?
|
Logistic Models | 1 | 2006 | 407 | 0.010 |
Why?
|
Age Factors | 1 | 2006 | 734 | 0.010 |
Why?
|
Adolescent | 1 | 2011 | 3121 | 0.010 |
Why?
|
CpG Islands | 1 | 2002 | 26 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 2002 | 76 | 0.010 |
Why?
|
Base Sequence | 1 | 2002 | 584 | 0.010 |
Why?
|
DNA | 1 | 2002 | 374 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2002 | 1574 | 0.010 |
Why?
|
Mice | 1 | 2002 | 4650 | 0.010 |
Why?
|